Floatz logo

L-Leucine

Delirium, Dementia, Amnestic, Cognitive Disorders

Washington University School of MedicineDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Delirium, Dementia, Amnestic, Cognitive Disorders cohort.

Asset / SponsorPhaseRating
Sra-333
New York State Psychiatric Institute
Phase 4BB
Intranasal Auto-M2-Bfs
Russian Academy of Medical Sciences
Phase 1/2CCC
Neurostem®-Ad
Duk Lyul Na
D

Same molecule, other indications

L-Leucine is also rated in:

major depressive disorderDormant
CCC
Indicative ·
53 / 100
View asset →
brain disorderDormant
D
Indicative ·
30 / 100
View asset →
Alzheimer diseaseDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →